Development of a novel metastatic breast cancer score based on hyaluronic acid metabolism

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Medical Oncology

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12032-012-0404-8PMID 23275142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discriminant function based on parameters of hyaluronic acid metabolism and nitric oxide to differentiate metastatic from non-metastatic colorectal cancer patients

  2012cited by this paper
• Clinicopathological Role of Serum-Derived Hyaluronan-Associated Protein (SHAP)-Hyaluronan Complex in Endometrial Cancer

  2011cited by this paper
• Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosis

  2011cited by this paper
• Diagnosis and Prognosis

  2010cited by this paper
• CA 15-3: uses and limitation as a biomarker for breast cancer.

  2010cited by this paper
• Measurement of serum N-acetyl beta glucosaminidase activity in patients with breast cancer.

  2009cited by this paper
• Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer.

  2009cited by this paper
• Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

  2006cited by this paper
• A study of serum glycosidases in cancer

  2005cited by this paper
• Hyaluronan synthase expression in ovarian cancer.

  2004cited by this paper
• Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL‐1), CD44v6 and microvessel density for prostate cancer

  2004cited by this paper
• Hyaluronan-oligosaccharide-induced transcription of metalloproteases

  2004influential reference
• Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: An in vitro and in vivo study

  2003cited by this paper
• Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors

  2003cited by this paper
• Hyaluronan-Cell Interactions in Cancer and Vascular Disease*

  2002cited by this paper
• Signaling Properties of Hyaluronan Receptors*

  2002cited by this paper
• Stromal and Epithelial Expression of Tumor Markers Hyaluronic Acid and HYAL1 Hyaluronidase in Prostate Cancer*

  2001cited by this paper
• Prognostic value of hyaluronan expression in non‐small‐cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma

  2001cited by this paper
• Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.

  2001cited by this paper
• 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.

  2001cited by this paper
• Heparanase: a key enzyme involved in cell invasion.

  2001cited by this paper
• Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.

  2000cited by this paper
• Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

  2000cited by this paper
• Tumour marker measurements in the diagnosis and monitoring of breast cancer.

  2000cited by this paper
• C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients.

  1999cited by this paper
• Prognostic relevance of tn expression in Breast Cancer

  1999cited by this paper
• Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation.

  1998cited by this paper
• Expression of hyaluronidase by tumor cells induces angiogenesis in vivo.

  1996cited by this paper
• Hyaluronan on the surface of tumor cells is correlated with metastatic behavior.

  1995cited by this paper
• Novel variants of CD44 arising from alternative splicing: Changes in the CD44 alternative splicing pattern of MCF‐7 breast carcinoma cells treated with hyaluronidase

  1993cited by this paper
• Serum immunoreactive beta-glucuronidase determined by an enzyme-linked immunosorbent assay in patients with hepatic diseases.

  1992cited by this paper
• Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen.

  1992cited by this paper
• Hyaluronan.

  1992cited by this paper
• 7th Jan Waldenström Lecture. The biology of human cancer metastasis.

  1991cited by this paper
• The biology of human cancer metastasis

  1991cited by this paper
• Sera of children with renal tumours contain low‐molecular‐mass hyaluronic acid

  1989cited by this paper
• Degradation of mucopolysaccharides by hepatic lysosomes.

  1966cited by this paper
• DETERMINATION OF GLUCURONIC ACID BY NAPHTHORESORCINOL.

  1964cited by this paper
• A method for the colorimetric determination of beta-glucuronidase in urine, serum, and tissue; assay of enzymatic activity in health and disease.

  1959cited by this paper
• A Method for the Colorimetric Determination of β-Glucuronidase in Urine, Serum, Tissue; Assay of Enzymatic Activity in Health and Disease

  1959cited by this paper
• Studies on glucosaminidase; N-acetyl-beta-glucosaminidase in rat kidney.

  1957cited by this paper
• Studies on glucosaminidase. N-Acetyl-β-glucosaminidase in rat kidney

  1957cited by this paper
• Method for the determination of hexosamines in tissues.

  1953cited by this paper

• The diagnostic utility of glycosaminoglycans (GAGs) in the early detection of cancer: a systematic review

  2024cites this paper
• Nanomedicine Strategies for Targeting Tumor Stroma

  2023cites this paper
• Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients

  2022cites this paper
• Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer

  2020cites this paper
• Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer

  2016cites this paper
• Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach

  2015cites this paper
• A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer

  2014cites this paper
• Extracellular Matrix Macromolecules in Tumour Microenvironment with Special Reference to Desmoplastic Reaction and the Role of Matrix Proteoglycans and Hyaluronan

  2013cites this paper